Results 31 to 40 of about 28,806 (223)

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial

Human Vaccines & Immunotherapeutics, 2019
Domestic measles, mumps, and rubella combined (MMR) vaccines were discontinued in 1993 in Japan because of the unexpected high incidence of aseptic meningitis. The introduction of an effective MMR vaccine with lower reactogenicity has been expected.
Tetsuo Nakayama, Masahiro Eda, Motonori Hirano, Wakako Goto   +3 more
doaj   +1 more source

Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: This is the first study in Indian paediatric subjects to evaluate the novel Measles, Mumps and Rubella (MMR) vaccine developed by M/s Cadila Healthcare Limited, India, containing the Hoshino mumps strain.
Rajesh Joshi, Neeta Hanumante, Uma Nayak, Shalaka Agarkhedkar, Paresh Thakkar, Jayesh Sanmukhani, Ravindra Mittal   +6 more
doaj   +1 more source

Knowledge synthesis of benefits and adverse effects of measles vaccination: the Lasbela balance sheet [PDF]

, 2009
Specific local conditions may explain the low rates of measles among the unvaccinated, while the high vaccine failure rate is likely due to weaknesses in the vaccination delivery system.
A Dale Horne, A Makela, AJ Schwarz, C Miller, CC White, CM Benjamin, CM Robertson, D Morley, DW Brock, F Destefano, Federal Bureau of Statistics, Government of Pakistan, FT Cutts, H Peltola, HA Simon, I Dourado, JJ Stokes, JM Dunlop, John Fleming, JS Titiyal, KM Madsen, L Kapiriri, L Pelletier, M Ceyhan, M Vestergaard, N Andersson, N Andersson, N Andersson, Neil Andersson, P Duclos, PM Strebel, PM Todd, RE Weibel, Robert J Ledogar, S Boyle, S Edees, S Makino, S Mitchell, SA Plotkin, SJ Lerman, SS Da Cunha, TA Swartz, TR Freeman, V Demicheli, World Health Organization, World Health Organization (WHO), World Health Organization (WHO)   +45 more
core   +4 more sources

The efficacy of 20% salicylic acid solution versus intralesional MMR vaccine combination with 20% salicylic acid solution in treatment of plane wart

Advanced Medical Journal
Background and objectives: Plane wart treatment is challenging; modalities such as cauterization and cryotherapy having a great probability to recur, as well as the risk of scarring, discomfort, and expensive costs.
Banu Muhammed Jaza Noori, Ali Mozan Dhahir Elethawi   +1 more
doaj   +1 more source

The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study

Pediatric Rheumatology Online Journal, 2021
Background Immunosuppressive drugs, incomplete vaccine coverage, immune system dysregulation might be factors of a low level of anti-vaccine antibodies in JIA patients. The study aimed to evaluate vaccine coverage, post-vaccine immunity, and risk factors
Mikhail M. Kostik, Natalia A. Lubimova, Irina V. Fridman, Olga V. Goleva, Susanna M. Kharit   +4 more
doaj   +1 more source

Measles Vaccination Before the Measles-Mumps-Rubella Vaccine

American Journal of Public Health, 2013
At the beginning of the 1960s, it was clear that a vaccine against measles would soon be available. Although measles was (and remains) a killer disease in the developing world, in the United States and Western Europe this was no longer so. Many parents and many medical practitioners considered measles an inevitable stage of a child’s development ...
Jan, Hendriks, Stuart, Blume
openaire   +3 more sources

An Evaluation of Mumps Antibody Titers Among Pharmacy Students Before and After a University Mumps Outbreak [PDF]

, 2017
Mumps outbreaks continue to transpire across the United States despite the available MMR (Measles-Mumps-Rubella) vaccine and seemingly high vaccination rates. There is limited evidence surrounding the management, impact, and prevention of mumps outbreaks.
Shelley, Kiley
core   +1 more source

Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024

Journal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs.
Nathan M. Money, Erin Sullivan, Hannah Rector, Corrie E. McDaniel, Jessica L. Markham, Mersine A. Bryan   +5 more
wiley   +1 more source

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine

Human Vaccines & Immunotherapeutics
Measles, mumps, and rubella (MMR) are highly infectious viral diseases affecting young children and have high secondary attack rates. Present MMR vaccines show consistent seroconversion rates for anti-measles and anti-rubella antibodies with variable ...
Nitin Shah, Apurba Ghosh, Kishore Kumar, Trayambak Dutta, Manish Mahajan   +4 more
doaj   +1 more source

A Social Controversy: Autism Spectrum Disorder\u27s Correlation to the Measles-Mumps-Rubella Vaccination [PDF]

, 2012
A 1998 research study lead by Dr. Andrew Wakefield linked the measles-mumps-rubella (MMR) vaccination as a probable cause to autism spectrum disorder.
Frye, Lindsay A
core   +1 more source